Menopause and Migraine: HRT, Aura and Headache Treatment

A migraine pattern you once understood can become unpredictable in perimenopause. Hormonal changes may help explain it, but a new headache or neurological symptom still deserves its own assessment.

If a migraine used to arrive the day before your period, changes in your cycle may make it harder to anticipate. Another pattern is a headache that worsens after starting hormone therapy, even as night sweats settle. The sequence matters because it helps a clinician consider hormonal triggers while assessing the headache on its own terms.

Migraine has treatments of its own. A clinician can consider those alongside menopause treatment, using your pattern, history and any unusual features to guide the choices.

IN THIS ARTICLE

When a headache needs urgent help
Why perimenopause can unsettle migraine
Aura changes the conversation, but not in the way every warning suggests
Can HRT help—or make migraine worse?
Treat the migraine itself
When rescue medicines become part of the problem
What to bring to the appointment
What about tingling, brain fog and other strange sensations?
Evidence and Canadian prescribing sources

When a headache needs urgent help

Call 911 for a sudden, extremely severe headache, particularly one that reaches maximum intensity within seconds or a minute; new facial droop, one-sided weakness, trouble speaking, sudden loss of vision or coordination; or a severe headache with collapse. Do not wait to see whether an unfamiliar neurological symptom turns out to be aura. Stroke symptoms can improve temporarily and still require emergency assessment.

A headache with fever and a stiff neck, significant head injury, or a painful red eye with altered vision also needs urgent assessment. A new headache after age 50 warrants prompt medical review. If it comes with scalp tenderness, jaw pain when chewing or visual symptoms, seek same-day urgent care: giant cell arteritis is one possible cause and can threaten sight. Sudden visual loss is an emergency.

Arrange an appointment for a steadily worsening or substantially changed headache pattern, first-ever aura, headaches triggered by exertion or coughing, or symptoms that disrupt work, driving or sleep. Pregnancy, the postpartum period, cancer or immune suppression can change the urgency of assessment. These boundaries matter even when you already have a migraine diagnosis.

Why perimenopause can unsettle migraine

Estrogen withdrawal is a recognized migraine trigger for some people. During perimenopause, hormonal fluctuations can become harder to predict, while disrupted sleep, irregular meals and stress may lower the threshold for an attack. The result can be more frequent migraine, a different menstrual relationship or attacks that seem unusually difficult to treat. That does not establish hormones as the cause of every new headache; blood pressure, medications, sleep disorders and other conditions still belong in the assessment.

Some people improve after natural menopause, once hormone levels are less variable. Others continue to have migraine, and surgical menopause can bring abrupt changes. It is reasonable to hope for improvement without being told to endure disabling attacks until your periods stop. If sleep is deteriorating too, our menopause sleep guide and sleep apnea guide explain problems that deserve attention alongside headache treatment.

Aura changes the conversation, but not in the way every warning suggests

Aura can include visual zigzags, flashing lights, spreading pins and needles or language symptoms. Typical aura develops gradually and each symptom usually lasts 5–60 minutes; it can occur without a subsequent headache. Those features help a clinician recognize a familiar pattern. They are not a home test for ruling out stroke, particularly with a first episode, sudden onset, weakness or symptoms unlike your usual attacks.

Migraine with aura is associated with a higher risk of ischemic stroke. Smoking, hypertension and other vascular risks therefore matter when choosing hormones. The important distinction is between combined hormonal contraception, used to prevent pregnancy and often containing ethinyl estradiol, and menopausal hormone therapy, usually using different hormones and doses. Combined estrogen-containing contraception is generally avoided in migraine with aura because of stroke risk. A patch used for contraception should not be confused with a transdermal estradiol patch prescribed for menopause.

Aura is not, by itself, an automatic prohibition on menopausal hormone therapy. British Menopause Society guidance updated in April 2026 supports individualized assessment and generally favours transdermal estradiol at the lowest dose that controls menopausal symptoms. That is a preference within a clinical risk assessment, not a promise that a patch is safe for everyone. Previous stroke, clotting disease and other contraindications require separate consideration.

Can HRT help—or make migraine worse?

Hormone therapy may help indirectly when it improves hot flashes and sleep, but it is not an established substitute for migraine prevention. A steady transdermal supply of estradiol is often preferred over oral estrogen for people with migraine because it avoids some fluctuations. More estrogen is not necessarily better: a dose that controls sweats may still aggravate headache or aura in an individual patient.

If headaches change after starting treatment, bring the timing of the change, the exact product and dose, patch changes or missed doses, bleeding pattern and aura history to the prescriber. A clinician may consider a different route, dose or progestogen schedule while checking for other causes. Do not increase estrogen, shorten patch intervals or stop prescribed endometrial protection on the basis of a discussion thread. New aura or a marked change needs review rather than an assumption that it is a harmless adjustment.

If you have a uterus, systemic estrogen generally requires adequate progestogen to protect the uterine lining. Continuous delivery may suit some migraine patterns, but the choice also depends on whether you are still menstruating and how bleeding is being managed. HRT does not provide contraception. Our Canadian hormone-therapy guide and HRT troubleshooting article provide the wider context.

Treat the migraine itself

An acute treatment plan aims to stop an attack; a preventive plan aims to reduce future attacks and their impact. Depending on your medical history, acute options can include an NSAID or acetaminophen, a triptan and medication for nausea. Triptans have important vascular contraindications, while NSAIDs may be unsuitable with ulcers, kidney disease or some other medicines. The most useful choice is one you can take appropriately and early enough, with a backup plan if it fails.

Canadian options also include the CGRP-receptor antagonists ubrogepant (Ubrelvy) and rimegepant (Nurtec ODT) for acute migraine in adults. Canadian Nurtec authorization is for acute treatment; do not assume an American preventive indication applies here. These medicines still require review for interactions, pregnancy considerations and other precautions. Availability in Canada does not mean that a provincial plan or private insurer will cover a particular prescription.

When attacks remain frequent or disabling, prevention deserves discussion rather than an endless sequence of rescue medicines. The Canadian Headache Society’s updated 2024 guideline covers established options such as topiramate, certain beta-blockers, candesartan and amitriptyline, as well as CGRP-targeted therapies. Atogepant (Qulipta) is a Canadian preventive option for episodic and chronic migraine; injectable CGRP therapies are another group. OnabotulinumtoxinA is used for chronic migraine. Selection depends on the headache pattern, other health conditions, adverse effects and pregnancy potential. Clinical recommendations and insurer eligibility rules are separate questions.

When rescue medicines become part of the problem

Medication-overuse headache is a recognized complication of frequent use of some acute medicines, not a moral failing or a reason to leave pain untreated. International diagnostic criteria use different thresholds: triptans, opioids and combination analgesics at 10 or more days a month, or simple analgesics such as acetaminophen and NSAIDs at 15 or more days a month, for more than three months, in the appropriate headache pattern. Count treatment days, not just tablets. These are diagnostic thresholds, not recommended targets or a guarantee of safety below them; gepants should not automatically be assigned the same evidence base.

If you are approaching frequent rescue use, ask for a preventive and withdrawal plan where needed. Do not abruptly stop a regularly used opioid without medical advice. Regular meals, manageable movement, consistent sleep and hydration can support treatment, but they do not replace it—and having an attack is not evidence that you failed to manage your lifestyle properly.

What to bring to the appointment

A few weeks of notes can reveal more than trying to reconstruct a bad month in ten minutes. Record headache days, severity, aura or other neurological symptoms, menstrual bleeding, sleep, hormone changes and every day you use acute medication. Include what you could not do because of the attack. The existing Maple Menopause symptom tracker can hold these notes; there is no need to start another elaborate system. Tracking should never delay assessment of a red flag.

Useful questions include: Is this still my established migraine pattern? Do I need preventive treatment? Does aura change my contraception choices? If HRT is appropriate, which route and regimen suit my risks? What is the next step if the first acute medicine fails? These questions keep the conversation focused on a workable plan, rather than whether you are “allowed” to have symptoms at this age.

What about tingling, brain fog and other strange sensations?

Not every symptom that feels neurological is migraine. Brain fog generally describes difficulty with attention, memory or word retrieval; sudden speech difficulty or confusion needs a different response. A pounding or irregular heartbeat belongs in a palpitations assessment, particularly with chest pain, fainting or breathlessness.

Persistent burning feet, numb fingers or crawling skin should not automatically be called “menopause neuropathy.” Nerve compression, diabetes, thyroid disease, vitamin deficiency, medication effects, skin conditions and other neurological problems can overlap. Note the location, duration, side, rash and any weakness. Progressive numbness or weakness needs assessment; sudden one-sided symptoms require emergency help. For symptoms involving the skin itself, see itching, burning and crawling sensations.

Evidence and Canadian prescribing sources

Evidence and Canadian product information checked November 6, 2026. This article provides education, not an individual diagnosis or prescription. New neurological symptoms require appropriate assessment.